Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Shlomo Melmed, MD
Cedars-Sinai Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Campus Charité Mitte
Berlin, Germany
- Endoc Center for Endocrine Tumors
Hamburg, Germany
- Max Planck Institute of Psychiatry
Munich, Germany
- Medizinische Klinik Innenstadt
Munich, Germany
- Praxis for Endocrimology and Diabetology in Oldenburg
Oldenburg, Germany
- Military Hospital, State Health Center 2nd Department of Internal Medicine
Budapest, Hungary
- Semmelweiss University
Budapest, Hungary
- University of Pecs
Pécs, Hungary
- University of Szeged
Szeged, Hungary
- Servizio Di Endocrinologia A.O. Spedali Civili Di Brescia
Brescia, Italy
- Dipartimento Clinico Sperimentale Di Medicina E Farmacologia
Messina, Italy
- Ospedale Molinette
Torino, Italy
- Hospital of Lithuanian University of Health Sciences Kauno Klinikos
Kaunas, Lithuania
- Vilnius University Hospital Santariskiu Clinics Center of Endocrinology
Vilnius, Lithuania
- Unidad de Investigacion Clinica Cardiometabolica de Occidente
Guadalajara Jalisco, Mexico
- Centro Medico Abc
Mexico City, Mexico
- Instituto Nacional de Neurologia Y Neurocirugía - National Institute of Neurology and Neurosurgery
Mexico City, Mexico
- Leiden University Medical Centre
Leiden, Netherlands
- Erasmus University Medical Center
Rotterdam, Netherlands
- Autonomous Public Clinical Hospital No. 5
Katowice, Poland
- Department of Endocrinology - Jagiellonian University, Krakow
Krakow, Poland
- Clinical Hospital of Medical University in Poznan
Poznan, Poland
- Bielanski Hospital
Warsaw, Poland
- Wroclaw Medical University
Wroclaw, Poland
- Endocrinology Institute C.I.Parhon
Bucharest, Romania
- County Emergency Hospital, Sf. Spiridon, Department of Endocrinology
Iași, Romania
- Clinic for Endocrinology, Diabetes and Metabolism Diseases, Clinical Center of Serbia
Belgrade, Serbia
- Clinical Center of Vojvodina
Novi Sad, Serbia
- University Hospital Bratislava, Hospital of L.Derer
Bratislava, Slovakia
- National Institute of Endocrinology and Diabetology
Ľubochňa, Slovakia
- Department of Endocrinology and Diabetes, University Medical Centre
Ljubliana, Slovenia
- University of Warwick - Medical School
Coventry, United Kingdom
- St Bartholomew'S Hospital West
London, United Kingdom
- the Christie Hospital Nhs Trust
Manchester, United Kingdom
- Oxford Centre for Diabetes, Endocrinology and Metabolism
Oxford, United Kingdom
- Cedars-Sinai Medical Center
Los Angeles, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2012
- Primary completion
- 31 May 2014
- Completion
- 31 May 2014
- Last update posted
- 17 Aug 2017
- Registered enrollment
- 155
- Registry id
- NCT01412424
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.